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Purpose of review 
 
Considerable uncertainty and controversy has existed concerning the 
management of convergence insufficiency. Only recently there have been 
significant scientific studies published that compare the effectiveness of the 
commonly prescribed treatments. This paper reviews the most recent 
research and literature on convergence insufficiency and its treatment. 
 
Recent findings 
 
The first large-scale placebo-controlled, randomized clinical trials to study 
the various treatments of convergence insufficiency have recently been 
published. Current research compares the effectiveness of base-in prism 
glasses, pencil push-ups, and vision therapy in reducing the signs and 
symptoms of convergence insufficiency and suggests that orthoptic therapy 
is the most efficacious treatment for convergence insufficiency. 
 
Summary 
 
Intensive orthoptic therapy is the treatment of choice for convergence 
insufficiency.  Pencil push-ups and use of accommodative targets have a role 
in the treatment of convergence insufficiency when used as part of a more 
intensive orthoptic program.  Base-in prism glasses should be reserved for 
reduction of symptoms in the presbyopic population. 
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Introduction 
 
In the evaluation of patients with ocular asthenopia, convergence 
insufficiency should be a part of the differential diagnosis. As convergence 
insufficiency is the most frequent cause for muscular discomfort it is of 
considerable clinical significance [1,2]. This condition is characterized 
by a patient’s inability to converge the eyes smoothly and effectively as the 
object of visual interest moves from distance to near and/or the inability to 
maintain the convergent near point. This ineffective muscular action can 
cause loss of proper binocular alignment with a resultant exophoria or 
intermittent exotropia at near. Associated with convergence insufficiency is 
a wide range of symptoms that can vary from mild to severe. Patients can be 
particularly distressed when they experience binocular diplopia at near. 
 
Historically the treatment for convergence insufficiency, especially vision 
therapy, has created controversy in both the ophthalmic and optometric 
communities [3_,4,5]. There has been a lack of consensus regarding the 
most beneficial treatment. Until recently, there had been a 
paucity of good scientific study. This paper reviews the etiology, 
symptomatology, diagnosis and most recent findings in the treatment of 
convergence insufficiency. 
 
 
 
 
Etiology and prevalence 
 
In 1855, von Graefe first described the symptoms of convergence 
insufficiency and thought it to be myogenic in origin [6,7]. In the recent 
past, convergence insufficiency was considered by some ophthalmologists to 
be a syndrome of asthenopic symptoms that, although manageable with 
orthoptic therapy, was thought to be psychogenic in origin and not curable 
because of the associated neuroses [1]. These views on etiology have not 
withstood the test of time. Our current understanding suggests an 
innervational etiology because of the frequent dramatic response to 
treatment both in the patient’s subjective improvement as well as the 
objective measurements of near point of convergence and fusional 
convergence amplitudes [8].  
 
The current reports sight a frequency of convergence insufficiency between 
2.25 and 8.3% but these numbers originate from clinical studies on school-
age children and university students [9]. Earlier reports find that incidence 
data varies from 1 to 25% [2]. Further study needs to be done to define the 
prevalence of this entity and determine if there is a familial predisposition as 
seen in other strabismic conditions. 
 
Symptoms 
 
The symptoms of convergence insufficiency can be highly variable. Some 
patients can have a significant convergence insufficiency and exhibit very 
few complaints. Others can have a very minimal convergence insufficiency 
and have severe symptoms. Most symptoms of convergence insufficiency 
are directly related to reading or other near tasks. The symptoms occur when 
there is an attempt at fusion and binocularity is present.  Patients with 
monofixation syndrome are less likely to be symptomatic. Similar to many 
strabismic conditions, the symptoms of convergence insufficiency can be 
aggravated by stress, illness or lack of sleep. Patients typically present with 
one or many of the following complaints:  
 
Headaches – The headache can occur during reading or after long periods of 
reading or, in my experience, may occur even without specific near tasks. 
The headaches are frequently located in the frontal area or are periocular. 
They are the result of the sustained effort to increase fusional convergence. 
The resultant headache from convergence insufficiency can potentiate other 
underlying headaches such as migraines. 
 Asthenopia – This can manifest as tired, strained eyes or eyes that hurt or 
feel sore with near work. Some patients may indicate that something is 
wrong with their eyes but will be vague or indefinite in their description of 
the problem. Patients also describe a pulling or pressure sensation around the 
eyes. These complaints result from the increased convergence and/or 
accommodative effort needed to maintain convergence.  
 
Difficulty with reading or near tasks -Patients will describe intermittent 
blurriness of words, print moving on the page, frequently loosing their place, 
lack of concentration or difficulty with comprehension while reading. 
Difficulty with reading for longer periods of time is common as the 
symptoms worsen with increased time at the near task. Some patients will 
not describe symptoms at near simply because of their strong avoidance of 
near vision tasks. 
 
Diplopia – This can present as two distinct images or an overlap of images. 
In convergence insufficiency, the images are horizontally displaced. Many 
patients will have difficulty deciphering the double images and will 
complain of blurriness of their vision. Some patients will close one eye to 
read to relieve the diplopia. Proper testing can further delineate the 
complaint related to diplopia as it will resolve with monocular acuity testing. 
Diplopia usually results from the related exodeviation at near seen with 
convergence insufficiency, but other forms of underlying strabismic 
tendency (e.g., esophoria) can become ‘uncovered’ when fusion is disrupted. 
 
Clinical findings 
 
The diagnosis of convergence insufficiency is based on the symptomatology 
as well as the physical findings. If the patient exhibits suppression then they 
may show many abnormal clinical findings without any of the symptoms 
discussed. The patient with convergence insufficiency may have an 
abnormality in any one or all of the following clinical findings: 
 
Remote near point of convergence 
 
A remote near point of convergence is the most consistent finding in 
convergence insufficiency (Fig. 1—AT END OF ARTICLE). There is little 
general consensus on what constitutes a normal near point. Clinical 
experience reveals that this measurement can be variable between patients. 
Normal young children have an excellent ability to converge and can 
maintain convergence easily 1–2 cm from their nasal bridge. Adults have 
slightly more difficulty but normally can maintain convergence in the 3–4 
cm range. Many authors use a remote near point of 10 cm to define patients 
with convergence insufficiency. The Convergence Insufficiency Treatment 
Trial (CITT) is using at least 6 cm as their inclusion criteria for their 
treatment studies. However, the child or adult with significant symptoms and 
other findings consistent with convergence insufficiency can have a receded 
near point as little as 4–5 cm from the nasal bridge. With careful observation 
one may see the patient with convergence insufficiency to have increased 
effort with convergence long before the near point is achieved. This can 
manifest as a slow and/or jerking movement, rather than the smooth 
consistent movement seen in normal convergence, or the development of an 
exodeviation with prolonged maintenance at a near point in excess of the 
patient’s capability. The abnormalities of convergence insufficiency are 
most easily seen while measuring near point of convergence using an 
accommodative target. 
 
Decreased fusional convergence 
 
The stimulus for fusional convergence at near is disparate retinal imagery 
[10]. Fusional convergence amplitudes or positive fusional vergence is the 
amount of convergence available to overcome temporal disparity in order to 
maintain binocular fusion at near. Base-out prisms are used to measure 
fusional convergence. To accomplish this measurement, the patient is 
instructed to keep a line of Snellen letters single and clear as base-out prism 
is added in a slow, gradual manner. Diplopia will occur when fusion is no 
longer possible. The amount of prism added to cause diplopia is the 
measurement of fusional convergence. The prism can then be reduced until 
fusion is re-established. This amount of prism is the recovery 
point. 
 
In convergence insufficiency it is common to see low fusional convergence 
amplitudes and thus an inability to maintain near fixation. The recovery 
point at which fusion is re-established after being broken can also be 
an indicator of fusional potential. As with low convergence amplitudes the 
recovery point will be receded as well. 
 
 
 
Phoria or tropia 
 
Most patients with convergence insufficiency will demonstrate varying 
degrees of exophoria or even an intermittent exotropia at near. The presence 
of orthophoria at near does not rule out convergence insufficiency. 
Some patients will have reduced stereoacuity at near. With distance fixation 
patients may have a small exophoria or be orthophoric. 
 
Treatment for convergence insufficiency  
 
Realizing the fact that not all patients with convergence insufficiency are 
symptomatic is important. Treatment for asymptomatic patients is generally 
unnecessary. Prescribed treatments for symptomatic patients include 
base-in prism reading glasses, pencil push-ups, orthoptics, vision therapy, 
and office-based vergence/accommodative therapy.   
 
Recently, the CITT Study Group is a collaborative multicenter effort and 
started the first large-scale placebo-controlled, randomized clinical trials to 
study the various treatments of convergence insufficiency [11,12]. This 
group also developed the Convergence Insufficiency Symptom Survey to 
quantify the severity of symptoms of convergence insufficiency to aid 
further study [13]. 
 
Base-in prism reading glasses 
Although base-in prism reading glasses have been used commonly to give 
symptomatic improvement in convergence insufficiency, there has been little 
scientific evidence to support its efficacy. Recently two studies have 
presented data, one in children and one in presbyopes [14,15_].   
 
The CITT Study Group found that base-in reading glasses were more 
effective than placebo reading glasses in improving symptoms and signs of 
convergence insufficiency in children aged 9 through 17 years. This study 
found that base-in prism reading glasses were no more effective than 
placebo reading glasses in relieving the symptoms of convergence 
insufficiency in children. Neither treatment group showed clinically 
significant changes in the near point of convergence or positive fusional 
convergence at near. The potential limitations of the study were the method 
of calculating the magnitude of the prism and the length of follow-up which 
was only 6 weeks. 
 
In symptomatic presbyopic adults aged 45–68 years, base-in prism was 
effective in decreasing symptomatology related to convergence 
insufficiency. One limitation of the study was the design of the prism glasses 
(not a commercially available option). This design had only a small range in 
the amount of prism that could be placed at near. Therefore additional prism 
was placed at both distance and near in some subjects. Whether the prism at 
distance induced some asthenopia or if possible prism adaptation occurred in 
some subjects was unclear and not controlled in this study. 
 
Pencil push-ups/accommodative target 
 
Pencil push-ups have been used as a mainstay of treatment for convergence 
insufficiency in both the optometric and ophthalmic communities. With 
pencil push-ups, the patient is instructed to maintain single 
vision as a target (commonly the pencil tip or eraser) is moved toward his or 
her nose. Many believe that an accommodative target (e.g., a letter or a 
picture with fine detail) should be used to facilitate accommodation 
and, hence, fusional convergence. Because of this, many use the letters on 
the pencil for fixation during pencil push-ups. Despite their frequent use, 
there have been very limited studies evaluating their effectiveness. 
A pilot study was performed prior to further studies by the CITT Study 
Group. This prospective, noncontrolled study evaluated the efficacy of 
pencil push-ups to determine if they could measurably change symptoms 
and findings in convergence insufficiency [16]. Although the study was 
inherently flawed by its design, it did show that pencil push-ups somewhat 
improved the near point of convergence and the positive fusional 
vergence. 
 
Further research from the CITT Study Group compared pencil push-ups to 
vision therapy/orthoptics and placebo vision therapy/orthoptics [9]. This 
study found that pencil push-ups were not effective in improving either the 
symptoms or signs associated with convergence insufficiency, and no more 
effective than placebo. Criticism of the study points out that pencil push-ups 
are rarely prescribed as the sole treatment for convergence insufficiency 
and are frequently prescribed as part of a more intensive orthoptic program 
[17]. The pencil push-ups in the study were performed using the tip of the 
sharpened pencil as the fixation target. Critics contend that an 
accommodative target is more frequently used to facilitate fusional 
convergence and that sustenance of convergence is important while doing 
the exercises [18]. Recent research has shown that sustained convergence 
does alter phorias and divergence dynamics [19]. Both an accommodative 
target and sustained convergence would intensify the pencil push-up therapy 
and may make it a more effective treatment. 
 
Orthoptic therapy/vision therapy/computer orthoptics 
 
‘Vision therapy’ has been one of the most controversial treatments for 
convergence insufficiency. Unfortunately, the term ‘vision therapy’ has 
come to include many types of intervention used for a wide variety of 
disorders including the underachieving child, reduction of myopia, 
sports issues, neurological disorders, and others, with lack of scientific 
support for these treatments [3_,20]. Despite these misapplications, there is 
recent strong and persuasive scientific data in the literature to support the 
use of some aspects of vision therapy for the treatment of convergence 
insufficiency [21–24,25__]. Standard vision therapy for convergence 
insufficiency, involving only orthoptic exercises, which includes 
vergence/accommodative therapy, can be accomplished on various 
computerized orthoptic programs. Other forms of ‘vision therapy’, including 
yoked prisms, low-plus lenses, colored or tinted lenses, biofeedback visual 
training, and others, are not treatments for convergence insufficiency. 
To differentiate orthoptic treatments under the global term ‘vision therapy,’ 
the use of the term orthoptic therapy or computer orthoptics will be used in 
this discussion. In the most current, widely used computer orthoptic 
program, the HTS Home Computer Therapy System (Computer Orthoptics, 
Gold Canyon, Arizona, USA), the patient is led through a series of exercises 
including saccades, pursuits, base-in and base-out stereograms, jump 
ductions and accommodation  
 
The CITT found that office-based orthoptic therapy/computer orthoptics is 
more effective than home-based pencil push-ups and placebo therapies in 
children 9–18 years old [9]. Their subsequent study showed that 12 weeks of 
office-based orthoptic therapy with home reinforcement resulted in greater 
improvement in symptoms and clinical measurements when compared with 
home-based pencil push-ups, home-based computer orthoptics and pencil 
push-ups, and office-based placebo therapy [26]. 
 
They also noted that children maintained their improvements in symptoms 
and signs for at least 1 year after discontinuing treatment [27_]. Further 
publication reviews and compares the results of all CITT trials and 
concludes that office-based orthoptic therapy/computer orthoptics is 
significantly more effective than home-based or placebo therapies [25__]. 
 
As other authors critique the work of the CITT Study Group they indicate 
that there are several issues for concern. The study groups were not equal in 
their treatments [17,28–30]. The in-office group being treated with 
orthoptics also had true home reinforcement and the placebo group did not. 
Also, the intensity of the officebased orthoptic therapy far surpassed the 
specific homebased orthoptic program. Yet, reviewing the current 
research and the subsequent editorials indicates that an intensive orthoptic 
program of some type can significantly reduce both the signs and symptoms 
of convergence insufficiency. 
 
A recent retrospective study showed that computer orthoptics delivered by 
the HTS system, the same system used for home-based therapy in the CITT 
trials, resulted in significant improvement in fusional amplitudes 
and pretherapy symptoms [31]. This study included patients prescribed the 
HTS program for a presumed accommodative/vergence disorder. The 
researchers were unclear as to the specific diagnosis thatwas being treated as 
they assessed the data from patient questionnaires via the internet. They 
concluded that office-based orthoptic treatment is not always practical,may 
be too expensive and may not be locally available. A home-based orthoptic 
program offers a cost-effective reasonable alternative. 
 
Conclusion 
 
Current research clarifies the efficacy of some long-standing treatments and 
indicates the potential for newer interventions such as home-based computer 
programs. An intensive orthoptic program appears to be the treatment 
of choice for reducing the signs and symptoms of convergence insufficiency. 
What is unclear from the current studies and editorials is the amount of time 
required to perform the therapy and the duration of treatment needed for 
successful and complete treatment of this entity. Additional studies are also 
needed to evaluate the treatment protocol for other age groups 
beyond 18 and less than 9 years. There appears to be a role for pencil push-
ups or accommodative targets in the treatment of convergence insufficiency 
when performed as part of a more intensive orthoptic program. 
 
Base-in prism glasses appear to be useful in decreasing the symptoms of 
convergence insufficiency in the presbyopic population. There seems to be 
little or no role of this therapy in the treatment of children age 9 through 17. 
Further studies are needed to elucidate whether this is appropriate and 
beneficial treatment for other age groups or for children who are resistant to 
other treatment modalities. 
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Figure 1 Remote near point of convergence 
 
 
 
 
This child shows exotropia at near as her near point has exceeded her 
ability to converge and maintain fusion. She was orthotropic for distance 
targets. 
